Nectin Therapeutics Licenses Novel ADC-Related Antibodies to Immunome

BeiGene Opens U.S. Facility to Boost ADC Development and Global Oncology Reach

BioAtla’s Ozuriftamab Vedotin Receives FDA Fast Track Designation for Recurrent or Metastatic Head and Neck...

Enhertu Faces Sales Challenges Amid Expansion Efforts by AstraZeneca and Daiichi Sankyo